Mednet Logo

What is your approach to a patient with positive antiphospholipid antibodies who otherwise do not meet clinical criteria for APS?

What if the patient is triple-positive or has continued seropositivity on repeat lab testing? What is the appropriate interval of monitoring and does management differ around high-risk procedures?
Community PollStarted

Do you use hydroxychloroquine for PRIMARY prevention of thrombotic complications in non-SLE patients with triple positive antiphospholipid antibodies?

53 physicians have voted

Join Mednetto vote and see how they answered.

3 Answers
Mednet Member
Mednet MemberInvited Expert
Rheumatology · SUNY Upstate Medical University
Answered on

As antiphospholipid antibodies constitute a diagnostic criterion of SLE, such patients may need to be evaluated and monitored long term for both SLE and APS.

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Rheumatology · UT Southwestern Medical Center
Answered on

Agree with Drs. @Dr. First Last and @Dr. First Last. To expand, women who have APLAs should avoid estrogen replacement and estrogen containing contraceptives. Progestin only contraception is preferred although, I/we generally recommend avoiding third generation progestins as these may increase the r...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Rheumatology · Hackensack University Medical Center
Answered on

Agree with the above.

In addition, improving modifiable risk factors for thrombosis is key for primary prevention in these patients (obesity, lipids, smoking, hypertension). Women with the high risk Ab profiles should be advised about the risk of oral contraceptives. Patients need to be aware of the...

Join for free or sign in to see the full answer